Role of Vitamins in Therapeutic and Targeting Approaches for Prostate Cancer: An Overview

被引:1
|
作者
Panda, Pritish Kumar [1 ,2 ]
Saraf, Shivani [1 ,3 ]
Verma, Amit [4 ]
Jain, Ankit [1 ,5 ,6 ]
Das Bidla, Pooja [1 ]
Raikwar, Sarjana [1 ]
Kumari, Priyanka [1 ]
Jain, Sanjay K. [1 ]
机构
[1] Dr Harisingh Gour Cent Univ, Dept Pharmaceut Sci, Pharmaceut Res Projects Lab, Sagar 470003, MP, India
[2] Haldia Inst Pharm, Inst ICARE, Dept Pharmaceut, Purba Medinipur 721657, West Bengal, India
[3] GLA Univ, Inst Pharmaceut Res, Mathura, India
[4] Amity Univ, Dept Pharmaceut, Gwalior 474005, MP, India
[5] Indian Inst Sci, Dept Mat Engn, Bangalore 560012, Karnataka, India
[6] Texas A&M, Irma Lerma Rangel Sch Pharm, 1010 W Ave B, Kingsville, TX 78363 USA
关键词
vitamins; combination; prevention; progression; nanocarriers; targeting; prostate cancer; OXIDATIVE STRESS; CELL-DEATH; E TPGS; COPOLYMER NANOPARTICLES; GENE-EXPRESSION; DIETARY-INTAKE; ASCORBIC-ACID; CO-DELIVERY; B VITAMINS; IN-VITRO;
D O I
10.2174/0113894501314558240822082557
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Vitamins play a crucial role in cellular functions like cell cycling and proliferation, differentiation, and apoptosis. These also help in the induction of cell cycle arrest and/or apoptosis. They can inhibit normal prostatic epithelial cell growth and might be helpful for the prevention of prostate cancer (PCa). Many essential vitamins including the fat-soluble vitamins (vitamin A, vitamin D, vitamin E, and vitamin K) and the water-soluble vitamins (vitamin B complexes and vitamin C) have a huge impact on the inhibition of growth and progression of PCa. Vitamins show anticancer properties and are involved in regulatory processes like the DNA repairing process, which inhibit the growth of PCa. Consumption of multivitamins prevents methylation of cancer cells and possesses an enormous potential that can be applied for the prevention as well as in the management of PCa. They have a great role in the inhibition of different signalling pathways involved in PCa. Moreover, they have also displayed a significant role in targeting of PCa with various nanocarrier systems. This review encompasses the recent studies about the individual actions of different vitamins and vitamin analogs, the combination of vitamins, and their efficient functions in various therapeutic and targeting approaches for PCa.
引用
收藏
页码:934 / 952
页数:19
相关论文
共 50 条
  • [41] Review deciphering potent therapeutic approaches targeting Notch signaling pathway in breast cancer
    Pandey, Pratibha
    Khan, Fahad
    Choi, Min
    Singh, Sujeet Kumar
    Kang, Han Na
    Park, Moon Nyeo
    Ko, Seong-Gyu
    Sahu, Sanjeev Kumar
    Mazumder, Rupa
    Kim, Bonglee
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 164
  • [42] Follistatin as potential therapeutic target in prostate cancer
    Sepporta, Maria Vittoria
    Tumminello, Francesca Maria
    Flandina, Carla
    Crescimanno, Marilena
    Giammanco, Marco
    La Guardia, Maurizio
    di Majo, Danila
    Leto, Gaetano
    TARGETED ONCOLOGY, 2013, 8 (04) : 215 - 223
  • [43] siRNA-based approaches for castration-resistant prostate cancer therapy targeting the androgen receptor signaling pathway
    Yu, Yanling
    Papukashvili, Dimitri
    Ren, Ruimin
    Rcheulishvili, Nino
    Feng, Shunping
    Bai, Wenqi
    Zhang, Huanhu
    Xi, Yanfeng
    Lu, Xiaoqing
    Xing, Nianzeng
    FUTURE ONCOLOGY, 2023, 19 (30) : 2055 - 2073
  • [44] Therapeutic potential of targeting AKR1C2 in the treatment of prostate cancer
    Nie, Mingyi
    Li, Tian
    Liu, Peng
    Wang, Xueni
    MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
  • [45] Nanoparticles for Targeting of Prostate Cancer
    Yari, Hooman
    Gali, Hariprasad
    Awasthi, Vibhudutta
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (42) : 5393 - 5413
  • [46] Emerging therapeutic frontiers in prostate health: Novel molecular targets and classical pathways in comparison with BPH and prostate cancer
    Hassan, Muhammad Sajjad
    Irfan, Hafiz Muhammad
    Alamgeer
    Sarwar, Muavia
    Jabbar, Zeeshan
    Nawaz, Shoaib
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2025, 206
  • [47] Targeted therapeutic approaches for hormone-refractory prostate cancer
    Stavridi, Flora
    Karapanagiotou, Eleni M.
    Syrigos, Kostas N.
    CANCER TREATMENT REVIEWS, 2010, 36 (02) : 122 - 130
  • [48] TRAIL and microRNAs in the treatment of prostate cancer: therapeutic potential and role of nanotechnology
    Farooqi, Ammad Ahmad
    De Rosa, Giuseppe
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2013, 97 (20) : 8849 - 8857
  • [49] Role of microRNAs in the development, prognosis and therapeutic response of patients with prostate cancer
    Ghafouri-Fard, Soudeh
    Shoorei, Hamed
    Taheri, Mohammad
    GENE, 2020, 759
  • [50] The role of clusterin in prostate cancer: treatment resistance and potential as a therapeutic target
    Muhammad, Lateef A.
    Saad, Fred
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (09) : 1049 - 1061